Search Orphan Drug Designations and Approvals
-
| Generic Name: | Parvovirus B19 (recombinant VP1 and VP2; S.frugiperda cells) vaccine |
|---|---|
| Date Designated: | 05/07/1999 |
| Orphan Designation: | Prevention of transient aplastic crisis in patients with sickle cell anemia. |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
MedImmune, Inc. 35 West Watkins Mill Rd. Gaithersburg, Maryland 20878 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







